
CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
The U.S. Centers for Disease Control have some caveats about pre-exposure prophylaxis treatment, which was recently found to dramatically lower HIV rates for men who have sex with men.
The CDC recently issued its first official guidelines on PrEP treatment after news broke in November that the therapy, involving the daily use of the AIDS drug Truvada, helps keep some people HIV-negative.
For more on this story, visit HIV Plus.
From our Sponsors
Most Popular
Watch Now: Pride Today
Latest Stories
How drag artists can protect themselves from the far-right attacks
July 14 2025 6:00 AM
Donald Trump threatens to revoke Rosie O'Donnell's citizenship — but he can't
July 12 2025 6:04 PM
Ahead of deadly Texas floods, so many warnings from climate scientists were missed
July 12 2025 7:00 AM
Louisiana Medicaid quietly stops reimbursing patients for gender-affirming care
July 11 2025 3:35 PM
Harvard seemingly caves to Trump, shuts down LGBTQ+ and women's center websites
July 11 2025 3:08 PM
How a gay HIV survivor helped Superman Christopher Reeve and was helped in return
July 11 2025 3:05 PM